Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients-Reference-Cited by-同舟云学术

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients

Published:2018-10-12 Issue:3 Volume:32 Page:405-414
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Bolivar Ana M.,Luthra Rajyalakshmi,Mehrotra Meenakshi,Chen Wei,Barkoh Bedia A.,Hu Peter,Zhang Wei,Broaddus Russell R.

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Red and Charline McCombs Institute Center for Global Cancer Early Detection

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-018-0158-8.pdf

Reference33 articles.

1. Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109:djx030.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

3. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491–505.

4. Pietrasz D, Pecuchet N, Garlan F, et al. Plasma circulating tumor DNA in pancreatic cancer patients is a prognostic marker. Clin Cancer Res. 2017;23:116–23.

5. Sausen M, Phallen J, Adleff V, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;6:7686. https://doi.org/10.1038/ncomms8686 .

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas;Journal of Gynecologic Oncology;2025

2. Angiogenesis in endometrial cancer: clinical and biological significance;Siberian journal of oncology;2024-09-10

3. Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer;Gynecologic Oncology Reports;2024-08

4. Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker;Frontiers in Oncology;2024-06-27

5. Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy;Cancers;2024-05-27